ArticleBone reports2026
Pilot proteomics study of three different human femur sites and autologous serum samples.
Article in Bone reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Tissue proteomics will help discover the molecular pathophysiology of bone diseases. So far, most human studies have been performed on serum/plasma samples. We present an initial pilot proteomics analysis comparing three clinically important anatomical femur sites (caput, collum, and trochanter). The specimens were obtained from osteoarthritic patients undergoing hip replacement surgery and represented predominantly cortical bone from collum and mostly trabecular bone from caput, together with a mixture from trochanter. The bone and the corresponding serum samples were analyzed by high-throughput data-independent acquisition (DIA) liquid chromatography-mass spectrometry (LC-MS/MS). The results showed that the protein composition of bone/bone marrow was substantially more complex than serum, presenting a total of 3085 and 597 detected proteins, respectively. A major part of the detected osteoblast/osteocyte, adipocyte, mesenchymal stem cell (MSC), and hematological/immunological characteristic proteins were similar between the corresponding femur sites in all donors and different from serum. Although the majority of the bone proteome was conserved across anatomical sites, exploratory analyses of the global proteomic landscape revealed site-specific protein signatures and associated functional pathways that were highly consistent across individuals. These findings suggest that anatomically adjacent femoral sites share a conserved core bone proteome while maintaining distinct molecular characteristics of potential functional relevance. With validation in larger cohorts, the results will contribute to the development of a human bone tissue proteomics atlas providing novel insight in the molecular microarchitecture and functionality relevant for bone health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.